Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0995 EUR | -1.49% |
|
+43.17% | +243.10% |
06-27 | PI Industries to Buy UK's Plant Health Care for 33 Million Pounds; Shares Up 3% | MT |
06-27 | INDIA STOCKS-UltraTech Cement, Reliance power Indian shares to record highs | RE |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Ratings chart - Surperformance
Sector: Agricultural Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+243.10% | 37.23M | - | ||
-18.38% | 14.31B | D+ | ||
-6.77% | 13.55B | B+ | ||
+9.40% | 12.89B | C | ||
-19.12% | 9.29B | B+ | ||
-.--% | 7.79B | - | C- | |
-14.84% | 7.35B | A- | ||
+27.90% | 5.66B | B- | ||
-18.86% | 5.45B | - | ||
+35.73% | 2.44B | C |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- PHC Stock
- PC5 Stock
- Ratings Plant Health Care plc